SCOTUS contraceptive ruling could have broader implications

The U.S. Supreme Court GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), told BioCentury that the key was the decision was made under the RFRA and in order for the court to reach its conclusion, it had to rule...